"332-bed Hospital, 24-hour Emergency Room, Lab Services, Cancer Services, Heart and Vascular Services, Inpatient and Outpatient Surgery, Rehabilitation Hospital, Imaging Services"

During the past decade, Roper Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 48 clinical trials were completed, i.e. on average, 154.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 28 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Roper Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 34 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Roper Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Roper Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (5 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Roper Hospital" in a lesser frequency.

Most popular intervention types in "Roper Hospital" are "Drug" (60 trials), "Other" (47 trials), "Biological" (26 trials), "Procedure" (8 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (34 trials), "Quality-of-Life Assessment" (16 trials), "Paclitaxel" (11 trials), "Bevacizumab" (9 trials) and "Docetaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Roper Hospital" are 59 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Roper Hospital". undefined are not yet recruiting, 6 are recruiting, 33 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Roper Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Roper Hospital, 0 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".